Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,196 results that match your search.22,196 results
  • Licensing arrangements provide the ability for a trade mark owner to generate revenue and capitalize on the reputation of their brands. The relationship between a licensor and licensee is, in many ways, an interdependent one. Therefore, trade mark owners carefully select licensing partners based on their reputation for quality and business acumen to ensure that the integrity of the licensor's valuable proprietary rights will be protected. Given the importance of this unique business relationship, licensors typically include language in their licensing agreements that requires the licensor's consent prior to any assignment by a licensee of the licensed rights and obligations.
  • MIP Brand Management Forum 2006, Great Eastern Hotel, London, UK, March 28 – 29.
  • Product piracy now threatens nearly every industry. Susanne Koch and Richard Dissmann of Bird & Bird examine the different means of dealing with the problem in Germany
  • As president of the German Federal Patent Court, Dr Hans-Georg Landfermann oversees decisions affecting the validity of all patents registered in Germany. Ben Moshinsky spoke to him about the role of the court and the future of European litigation
  • The recent case of Schering-Plough v Norbrook (Schering-Plough Ltd v Norbrook Laboratories Ltd [2005] EWHC 2532) provides a useful summary of the law on obviousness, particularly the scope of the "obvious to try" test.
  • According to Turkish Patent Decree Law, a patentee is obliged to put to use/work the invention under patent protection and file a certified document to the Turkish Patent Institute within three years from the date when the patent was granted. Otherwise any interested person may request that a compulsory licence be granted.
  • As a result of the exception provided by the European Patent Convention, before October 7 1992 Spain did not accept the patentability of chemical and pharmaceutical products. This is why European patents which claimed products had to include a special set of claims for Spain with only process claims.
  • Search and examination procedures in Singapore have been amended to bring them in line with changes in the Singapore Patents Act relating to patent applications with filing dates after July 1 2004. For PCT National Phase entry applications into Singapore, the effective filing date is the international filing date. Therefore, the majority of PCT National Phase entry applications now fall under the new law.